West Nile Virus (WNV) diagnosis in a laboratory setting typically involves analyzing serum or cerebrospinal fluid (CSF) to detect WNV-specific IgM antibodies. Several commercial immunoassays, as well as those available through state public health laboratories, are utilized for this purpose.
WNV-specific IgM antibodies usually become detectable in a patient’s system around 3 to 8 days after the onset of illness. These antibodies can persist for a considerable period, typically 30 to 90 days, although in some cases, they have been documented to last even longer. Due to this persistence, the presence of IgM antibodies might sometimes indicate a past infection rather than a current one. Importantly, if a blood sample is taken within the first 8 days of illness, a negative IgM result doesn’t necessarily exclude a WNV infection. In such cases, repeat testing on a later sample might be required to confirm or rule out the diagnosis.
While the detection of WNV-specific IgM in serum or CSF is strong evidence of a recent infection, it’s crucial to note that cross-reactivity with antibodies from other flavivirus infections, or even non-specific reactivity, can occur. Therefore, in certain scenarios, positive results from these initial assays should be verified through neutralizing antibody testing, conducted at a state public health laboratory or the Centers for Disease Control and Prevention (CDC). Plaque-reduction neutralization tests (PRNTs) are instrumental in pinpointing the specific flavivirus responsible for the infection. PRNTs are also valuable for confirming acute infection by demonstrating a significant increase – a fourfold or greater change – in WNV-specific neutralizing antibody levels between acute-phase and convalescent-phase serum samples, taken 2 to 3 weeks apart.
Confirmatory testing using PRNTs is particularly indicated in situations such as:
- Potential exposure to other flaviviruses that could cause cross-reactions, like St. Louis encephalitis virus or dengue virus.
- Cases presenting with atypical or unusually severe symptoms, or in cases of death.
- Suspicion of unusual transmission routes, such as organ transplant, blood transfusion, or laboratory exposure.
- Presentation of symptoms outside the typical arboviral season, which is generally from April to October.
WNV IgG antibodies generally appear shortly after IgM antibodies. These IgG antibodies can remain detectable for many years following both symptomatic and asymptomatic WNV infections. Consequently, the sole presence of IgG antibodies only indicates a past infection. Clinically suspected cases showing IgG but not IgM should be further investigated for other potential causes.
Besides antibody testing, other diagnostic methods exist. Viral cultures and tests designed to detect viral RNA, such as RT-PCR, can be performed on serum, CSF, and tissue samples. These samples must be collected early in the illness course to maximize detection probability. Positive results from these tests are highly confirmatory of a WNV infection. However, in immunocompetent patients, the likelihood of detecting WNV infection through molecular testing is relatively low. In contrast, patients with compromised immune systems may experience prolonged viremia and delayed or absent antibody responses. For these individuals, molecular testing might be a more suitable diagnostic approach.
Immunohistochemistry (IHC) is another technique that can identify WNV antigen in formalin-fixed tissue samples. It’s important to note that negative results from IHC, as with other tests, do not entirely rule out WNV infection. Viral culture, RT-PCR, and IHC can be requested through state public health laboratories or the CDC.
For assistance with diagnostic testing, reaching out to your state or local health department is recommended. They can guide you in determining whether samples should be sent to the CDC Arbovirus Diagnostic Laboratory for more specialized testing.
West Nile Virus disease is a nationally notifiable condition. It is crucial to report all diagnosed cases to local public health authorities promptly. This reporting is vital for aiding local, state, and national health bodies in recognizing outbreaks and implementing effective control measures to limit further infections.
Keep Reading: Diagnostic Testing Algorithm for Suspected West Nile Virus Disease
Keep Reading: West Nile Virus Clinician Training – Free CME
